Project

A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of BG00012 monotherapy with Relapsin Remitting Multiple Sclerosis

Automatically Closed · 2010 until 2020

Müller Stefanie, Vehoff Jochen